We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+9.12%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$13.2B
AUM Growth
+$1.19B
Cap. Flow
+$398M
Cap. Flow %
3.01%
Top 10 Hldgs %
25.15%
Holding
2,888
New
90
Increased
233
Reduced
1,480
Closed
57

Top Sells

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$33.4M
2
AAPL icon
Apple
AAPL
+$20.4M
3
MSFT icon
Microsoft
MSFT
+$10.9M
4
TWTR
Twitter, Inc.
TWTR
+$9.15M
5
Y
Alleghany Corp
Y
+$7.32M

Sector Composition

Rank Sector Weight
1 Technology 19.63%
2 Healthcare 13.34%
3 Financials 12.1%
4 Consumer Discretionary 9.16%
5 Industrials 9.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBEX icon
2526
IBEX
IBEX
$472M
$117K ﹤0.01%
+4,706
New +$106K
FWRG icon
2527
First Watch Restaurant Group
FWRG
$805M
$117K ﹤0.01%
+8,639
New +$132K
COIN icon
2528
Coinbase
COIN
$39.7B
$117K ﹤0.01%
3,300
+53
+2% +$2.79K
TRUE
2529
DELISTED
TrueCar
TRUE
$117K ﹤0.01%
+46,466
New +$96.6K
PATH icon
2530
UiPath
PATH
$7.97B
$117K ﹤0.01%
9,170
+73
+0.8% +$902
KRO icon
2531
KRONOS Worldwide
KRO
$938M
$116K ﹤0.01%
12,349
SRTA
2532
Strata Critical Medical Inc
SRTA
$532M
$116K ﹤0.01%
32,344
AURA icon
2533
Aura Biosciences
AURA
$793M
$116K ﹤0.01%
11,026
BFAM icon
2534
Bright Horizons
BFAM
$3.77B
$116K ﹤0.01%
1,833
-22
-1% -$1.44K
PEPG icon
2535
PepGen
PEPG
$199M
$116K ﹤0.01%
+8,647
New +$112K
CTRN icon
2536
Citi Trends
CTRN
$616M
$115K ﹤0.01%
+4,339
New +$102K
PACK icon
2537
Ranpak Holdings
PACK
$469M
$115K ﹤0.01%
19,863
DGICA icon
2538
Donegal Group Class A
DGICA
$706M
$114K ﹤0.01%
8,017
CBNK icon
2539
Capital Bancorp
CBNK
$617M
$114K ﹤0.01%
4,831
UVE icon
2540
Universal Insurance Holdings
UVE
$1.18B
$113K ﹤0.01%
10,701
-4,018
-27% -$40.9K
GWH icon
2541
ESS Tech
GWH
$20.1M
$113K ﹤0.01%
3,109
UPLD icon
2542
Upland Software
UPLD
$15.5M
$113K ﹤0.01%
1,588
PRME icon
2543
Prime Medicine
PRME
$579M
$113K ﹤0.01%
+6,091
New +$110K
PLPC icon
2544
Preformed Line Products
PLPC
$2.27B
$113K ﹤0.01%
1,356
ELAN icon
2545
Elanco Animal Health
ELAN
$11.1B
$112K ﹤0.01%
9,203
+45
+0.5% +$561
JYNT icon
2546
The Joint Corp
JYNT
$125M
$112K ﹤0.01%
8,041
PKBK icon
2547
Parke Bancorp
PKBK
$411M
$112K ﹤0.01%
5,407
VRT icon
2548
Vertiv
VRT
$112B
$112K ﹤0.01%
8,181
-51
-0.6% -$680
TK icon
2549
Teekay
TK
$1.06B
$111K ﹤0.01%
24,557
-13,318
-35% -$55.3K
FF icon
2550
Future Fuel
FF
$253M
$111K ﹤0.01%
+13,694
New +$103K

Similar funds

MetLife Investment Management's Q4 2022 Portfolio in Review

As of Q4 2022, MetLife Investment Management held 2,888 positions worth $13.2B, up 9.9% from $12B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

MetLife Investment Management deployed $398M of net new capital in Q4 2022, opening 90 new positions and adding to 233 existing holdings. Its largest new stake was Atlassian: 8,691 shares worth $1.12M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $33.4M trimmed.

  • MetLife Investment Management's largest Q4 2022 buy was Atlassian: 8,691 shares worth $1.12M.
  • MetLife Investment Management added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2022, an estimated $651M increase.
  • MetLife Investment Management's biggest Q4 2022 reduction was iShares MSCI EAFE ETF, cutting an estimated $33.4M.
  • MetLife Investment Management fully exited Twitter, Inc. in Q4 2022, selling an estimated $9.15M.
  • MetLife Investment Management's ten largest holdings make up 25% of its $13.2B portfolio in Q4 2022.
  • MetLife Investment Management opened 90 new positions and closed 57 in Q4 2022.
  • MetLife Investment Management's portfolio value rose 9.9% quarter-over-quarter to $13.2B.

Based on MetLife Investment Management's 13F filing for Q4 2022, filed 15 Feb 2023.